Yeung C H, Schröter S, Wagenfeld A, Kirchhoff C, Kliesch S, Poser D, Weinbauer G F, Nieschlag E, Cooper T G
Institute of Reproductive Medicine, University, Münster, Germany.
Mol Reprod Dev. 1997 Oct;48(2):267-75. doi: 10.1002/(SICI)1098-2795(199710)48:2<267::AID-MRD15>3.0.CO;2-V.
A monoclonal antibody (CAMPATH-1 G) against the human lymphocyte surface protein CD52, which is similar to the epididymal secretion HE5, was used to ascertain the presence of this protein on maturing primate spermatozoa by flow cytometry. The percentage of human viable spermatozoa stained specifically with this antibody increased from sperm in spermatocoeles (0.5%), to the efferent ducts (3.8%), corpus (47.2%), and cauda (85.7%) epididymidis. Positive cells revealed staining mainly over the whole tail and postacrosomal region of the sperm head. Spermatozoa (approximately 10%) from both the efferent ducts and corpus epididymidis took up additional antigen when incubated with human distal cauda epididymidal plasma as a source of CD52, and 12-22% of human testicular sperm (from spermatocoeles) took up CD52 from human seminal plasma. In the cynomolgus monkey, nonspecific binding of control IgG was greater than that in human males and net CD52 staining was measurable only on approximately 30% of corpus sperm where it was mainly on the principal piece. Neither caput nor cauda sperm took up human CD52 upon incubation with human seminal plasma, but an additional 27% of corpus sperm expressed CD52. Such uptake of CD52 was drastically reduced, or did not occur, when seminal plasma had been fractionated by filtration through 0.1 microns filters (filtrate II) or 300,000 Da cutoff filters (filtrate III), respectively. Western blots revealed that CD52 contents were much reduced in filtrate II and nondetectable in filtrate III of seminal plasma. Similar reduction of CD52 in the filtrate of cauda epididymidal plasma indicates the association of this epididymal secretion with large molecular factors and suggests their involvement as carriers in the in vivo transfer of the secretion onto the epididymal sperm surface. The in vitro uptake of CD52 by some but not all immature sperm and the detection by Western blotting of much less CD52 in the corpus than the cauda luminal plasma suggest that the acquisition of this epididymal secretion by spermatozoa depends on their maturation status as well as the availability of the protein in the epididymal lumen.
一种针对人类淋巴细胞表面蛋白CD52的单克隆抗体(CAMPATH-1 G),其与附睾分泌物HE5相似,被用于通过流式细胞术确定这种蛋白在灵长类动物成熟精子上的存在情况。用该抗体特异性染色的人类活精子百分比从精囊肿中的精子(0.5%),增加到输出小管(3.8%)、附睾体(47.2%)和附睾尾(85.7%)中的精子。阳性细胞的染色主要出现在精子头部的整个尾部和顶体后区域。当与作为CD52来源的人类附睾尾远端血浆一起孵育时,来自输出小管和附睾体的精子(约10%)摄取了额外的抗原,并且12 - 22%的人类睾丸精子(来自精囊肿)从人类精液血浆中摄取了CD52。在食蟹猴中,对照IgG的非特异性结合比人类男性更强,并且仅在约30%的附睾体精子上可检测到净CD52染色,且主要位于主段。附睾头和附睾尾的精子与人类精液血浆孵育后均未摄取人类CD52,但另外27%的附睾体精子表达了CD52。当精液血浆分别通过0.1微米滤器(滤液II)或300,000 Da截留滤器(滤液III)过滤分级后,这种CD52的摄取显著减少或未发生。蛋白质印迹显示,精液血浆滤液II中的CD52含量大幅降低,滤液III中未检测到。附睾尾血浆滤液中CD52的类似减少表明这种附睾分泌物与大分子因子有关,并提示它们作为载体参与了该分泌物在体内向附睾精子表面的转移。一些但并非所有未成熟精子在体外摄取CD52,以及蛋白质印迹检测到附睾体管腔血浆中的CD52比附睾尾少得多,这表明精子对这种附睾分泌物的获取取决于它们的成熟状态以及附睾管腔中该蛋白的可利用性。